NEW YORK--(BUSINESS WIRE)--Paige, a global leader in end-to-end digital pathology solutions and clinical AI applications, and OptraSCAN®, a leading producer of whole slide scanners, today announced a partnership to streamline the adoption of...

Paige: Custom platform tailored to needs of market leader in clinical diagnostics to facilitate better integration, collaboration and workflows for faster diagnosis; better patient and staff experience NEW YORK–(BUSINESS WIRE)–Paige, a...

In a tongue twister of a collaboration, partners Paige and Perspectum plan to pool pathology tools to progress prospective studies. Both companies are developing artificial intelligence-powered software that analyzes standard tissue...

Paige: Company announces CE-IVD and UKCA designations of its new digital biomarker assay, HER2Complete, to identify patients with expression of HER2 in breast cancer The tool has revealed HER2 expression in HER2-negative and HER2-low...

Paige and Janssen will collaborate to deploy an AI-powered, H&E-based biomarker test, developed by Janssen, to screen for actionable FGFR2 and FGFR3 genomic alterations within seconds Goal is to provide physicians with important insights...

Join Paige on Wednesday, 15th June at ECDP’s Pre-Conference Workshop to learn why generalizability is critical for AI in clinical use. Not attending ECDP in person? Register now for exclusive access to Paige’s live stream from the...